FROM THE TEAM
Members of the Cubic Health Management Team had the opportunity to attend this year's Annual Meeting for the Academy of Managed Care Pharmacy (AMCP) in San Francisco in April. Always a wealth of information and insight into emerging issues and trends in drug plan benefit design, the pharmaceutical and biopharmaceutical pipelines, and managed health care in general, this year's conference was no different! For a discussion of some key trends and insights presented during the event, please see the article in this issue called, "Insight into Future Trends from South of the Border".
The Management Team would also like to take this opportunity to welcome the latest addition to our team, Ken Chiu, as our new Data Analyst. In this role, Ken will be responsible for the management of our Cubic Health Canadian Drug Database™, the engine behind our extensive analytics and reporting capabilities, and will be assisting us in the preparation of client deliverables on the reporting side. Ken brings with him a background in IT and health informatics and we look forward to him applying his knowledge and fresh insight to drug plan management in Canada. Welcome, Ken!
To pass along any comments on Cubic Health Monthly, or to see back issues of our publication, please visit our website at http://www.cubichealth.ca
Sincerely,
Chris von Heymann
Senior Vice President
| LATEST NEWS |
Insight into Future Trends from South of the Border
At the Annual Meeting of the Academy of Managed Care Pharmacy (AMCP) in April, a broad spectrum of topics were covered including the current pharmaceutical landscape, trends in benefit design, a renewed vigilance towards improving adherence to therapy among plan members, and other considerations for plan sponsors. Due to the faster approval of new drug products and the managed nature of prescription drug plans south of the border, the U.S. experience provides some insight as to the future impact of these products in Canada.
Click here to read more...
|
| DRUG & DISEASE NEWS |
|
|
NOC Watch:
Ran™- Pantoprazole and Apo®-Pantoprazole (Pantoprazole)
Simvasa (simvastatin and acetylsalicylic acid)
Volibris® (ambrisentan)
Click here to read more...
|
| FOR THE PLAN SPONSOR |
Brand Classification: A Review for Non-Healthcare Professionals
Although there are over 2,500 prescription drugs catalogued in the CPS (the Compendium of Pharmaceutical Specialties, the Canadian drug "bible"), they can all be group into 4 major categories based on their brand status. The brand status has nothing to do with the therapeutic use of the drug and everything to do with drug patents.
Click here to read more...
|
|
